Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Pittsburgh
Washington University School of Medicine
University of Southern California
Massachusetts General Hospital
University of Virginia
Icahn School of Medicine at Mount Sinai
Ludwig Institute for Cancer Research
Washington University School of Medicine
University of Virginia
Case Comprehensive Cancer Center
Icahn School of Medicine at Mount Sinai
Celldex Therapeutics
Rutgers, The State University of New Jersey